Patients Stopping Anti-Obesity Injections Regain Weight Far More Rapidly Compared to Those on Conventional Diets

Fresh analysis indicates that individuals who come off blockbuster GLP-1 drugs like Mounjaro or Wegovy may regain lost weight far faster than those who halt conventional diet and exercise regimens.

Research printed in a prominent medical journal shows that while overweight individuals often shed about a fifth of their body weight while undergoing treatment, the weight comes back at an average rate of nearly a kilo each month upon discontinuation.

"People using such medications must be cognizant of the potential of fast weight regain when the medication ends," warns researcher Dr. Susan Jebb.

This pace of regain means a return to pre-treatment mass within about a year and a half.

Weighing Approaches

The study, which reviewed dozens of studies involving thousands of participants, compared the outcomes of the injectable medications with other pills.

Researchers point out that people who lose weight through diet and exercise generally have a less rapid weight regain—perhaps 0.1 kg a month—once they finish.

Explaining the Quick Rebound

Experts believe the way of the drugs explains the heightened weight return.

These medications imitate a natural hormone called GLP-1, which helps regulate hunger.

"Artificially providing the hormone concentrations far above than the body's typical production could lead to the body to generate a reduced amount of its own natural hormone, and may also reduce sensitivity to its effects," explained Dr. Adam Collins, a dietetics specialist.

"Discontinuation of this hormone supplement means appetite is uncontrolled, making binge eating a significant risk."

A Chronic Issue?

Health authorities recommend the injections for people with obesity-related health risks, accompanied by prescribed diet and exercise modifications.

A number of clinicians say that, considering the likelihood of relapse, the therapy should be considered ongoing.

This opinion is supported by pharmaceutical companies, who state that the findings "highlight the persistent nature of obesity," akin to managing conditions like diabetes.

User Testimonies

Users who have stopped the medication describe a intense resurgence of appetite.

"It was like a trigger that goes on and I was suddenly ravenous," said an individual.

This challenge is worsened if patients have not developed lasting lifestyle or habit modifications during treatment.

Growing Interest

Recent estimates show that a significant number of people in the UK have tried these injections in the last 12 months, with interest continuing to grow.

• Adoption is greater among women compared to males.
• The middle-aged demographic shows the highest level of interest.
• A large proportion obtain the medications through private prescriptions rather than the NHS.

Ultimately, experts stress that while the jabs are effective agents for shedding pounds, they are not a magic fix and long-term success relies on ongoing lifestyle support.